Based on PubMed | Are heart palpitations a recognized symptom in endometrial cancer, and do they have any impact on prognosis?

Heart palpitations are not a typical presenting symptom of endometrial cancer, and there is no evidence that palpitations themselves influence prognosis; classic symptoms are abnormal uterine bleeding and, less commonly, pelvic pain, while palpitations are more often related to treatment side effects (for example, chemotherapy- or immunotherapy‑related thyroid or cardiac issues) or to coexisting heart conditions. ^{[1] [2] [3]}

What symptoms are typical in endometrial cancer

• The most common early sign is abnormal vaginal bleeding (postmenopausal bleeding, bleeding between periods, or unusually heavy or prolonged bleeding). ^[2]
• Some people have pelvic cramping or lower abdominal pain, especially in more advanced disease. ^[2]
• In cohort studies, most individuals present with postmenopausal or irregular bleeding; pain is less common and tends to be linked with more advanced stage at diagnosis. ^{[3] [4]}

Are palpitations part of the disease itself?

• Standard symptom lists for endometrial cancer do not include palpitations as a primary sign of the tumor. ^{[1] [2]}
• Palpitations can occur for other reasons during the cancer journey, including anemia from bleeding, anxiety, dehydration, fever, preexisting arrhythmia, or treatment‑related effects on the heart or thyroid. While anemia can cause a fast heartbeat, it stems from blood loss rather than a direct tumor effect. ^[2]

When palpitations may appear during treatment

• Certain chemotherapy regimens that include anthracyclines (such as doxorubicin) can cause heart problems, which may present as chest discomfort, shortness of breath, leg swelling, or an abnormal heartbeat; these issues can emerge during therapy or be delayed for months to years after treatment. ^{[5] [6]}
• Immunotherapy combinations (for example, regimens that include dostarlimab or durvalumab) can trigger thyroid problems; an overactive thyroid may cause a faster‑than‑usual heartbeat, sweating, and heat intolerance, whereas an underactive thyroid can cause fatigue, weight gain, and slow heart rate. ^{[7] [8]}
• Some regimens also warn of uncommon but potentially serious cardiac effects, where a faster heartbeat or chest symptoms should prompt urgent evaluation. ^{[9] [10]}

Do palpitations affect prognosis in endometrial cancer?

• Published studies linking presenting symptoms to outcomes show that abnormal bleeding is the dominant presentation, and that “other” presentations (including pain) may correlate with more advanced stage and worse survival; palpitations are not cited as a prognostic presenting symptom. ^[3]
• Overall survival in endometrial cancer is most strongly tied to tumor stage, grade, histology, and patient factors, not to palpitations. Early‑stage disease has high 5‑year survival, while distant spread is associated with lower survival. ^[11]
• Importantly, among people diagnosed with endometrial cancer especially those with early, low‑grade disease cardiovascular disease becomes a leading cause of death over time, surpassing cancer‑specific mortality about five years after diagnosis; this highlights the need to monitor and manage heart risk factors, but it does not mean palpitations themselves worsen cancer prognosis. ^[12]

Practical takeaways

• Palpitations are not a recognized hallmark symptom of endometrial cancer and do not have a known direct impact on cancer prognosis. ^{[1] [3]}
• New or worsening palpitations warrant medical review because they can signal treatment‑related cardiac or thyroid issues that may need prompt care. ^{[5] [7]}
• If palpitations occur alongside chest pain, shortness of breath, fainting, or leg swelling during or after therapy, urgent evaluation is advisable. ^{[5] [9]}
• Long‑term care should include attention to cardiovascular health, as heart disease is a major cause of mortality among endometrial cancer survivors. ^[12]

Bottom line

• Abnormal uterine bleeding is the key symptom associated with endometrial cancer, not heart palpitations. ^{[2] [1]}
• Palpitations during the cancer course are more likely related to anemia, anxiety, preexisting heart conditions, or treatment‑related thyroid or cardiac effects; these should be assessed clinically but are not known to alter endometrial cancer staging or survival. ^{[5] [7] [3] [11] [12]}